Algert Global’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.88M | Buy |
127,188
+111,021
| +687% | +$1.64M | 0.04% | 650 |
|
|
2025
Q1 | $290K | Hold |
16,167
| – | – | 0.01% | 1020 |
|
|
2024
Q4 | $282K | Buy |
+16,167
| New | +$282K | 0.01% | 1003 |
|
|
2024
Q1 | – | Sell |
-83,840
| Closed | -$754K | – | 1278 |
|
|
2023
Q4 | $754K | Buy |
83,840
+4,470
| +6% | +$40.2K | 0.03% | 693 |
|
|
2023
Q3 | $710K | Buy |
79,370
+27,070
| +52% | +$242K | 0.03% | 643 |
|
|
2023
Q2 | $803K | Buy |
+52,300
| New | +$803K | 0.03% | 704 |
|
|
2023
Q1 | – | Sell |
-47,422
| Closed | -$997K | – | 1312 |
|
|
2022
Q4 | $997K | Sell |
47,422
-10,200
| -18% | -$214K | 0.06% | 571 |
|
|
2022
Q3 | $1.42M | Buy |
57,622
+4,720
| +9% | +$116K | 0.09% | 402 |
|
|
2022
Q2 | $1.28M | Buy |
52,902
+27,780
| +111% | +$673K | 0.1% | 371 |
|
|
2022
Q1 | $647K | Buy |
+25,122
| New | +$647K | 0.04% | 715 |
|
|
2018
Q4 | – | Sell |
-13,130
| Closed | -$377K | – | 422 |
|
|
2018
Q3 | $377K | Hold |
13,130
| – | – | 0.08% | 279 |
|
|
2018
Q2 | $358K | Buy |
+13,130
| New | +$358K | 0.07% | 267 |
|